Showing results (1-10 of 721) with videos related to

Sort By:
Pageof 73
Neuro-Oncology Practice|November 15, 2021
Impact of MRI timing on tumor volume and anatomic displacement for brain metastases undergoing stereotactic radiosurgeryTugce Kutuk, Ranjini Tolakanahalli, Andre Williams, et al.
Neuro-Oncology Practice|November 15, 2021
Pilot study of smartphone-based health outcome tracking (OurBrainBank) for glioblastoma patientsJacob G Ellen, Florien W Boele, Bruce Hellman, et al.
Neuro-Oncology Practice|November 15, 2021
Assessment of neurological function using the National Institute of Health Stroke Scale in patients with gliomasAnna Maria Zeitlberger, Marie-Claire Flynn, Monika Hollenstein, et al.
Neuro-Oncology Practice|August 14, 2019
Corrigendum
Neuro-Oncology Practice|August 14, 2019
Corrigenda: Residual enhancing disease after surgery for glioblastoma: evaluation of practice in the United KingdomRuichong Ma, Aswin Chari, Paul M Brennan, et al.
Neuro-Oncology Practice|October 4, 2019
Clinical outcome assessments in neuro-oncology: a regulatory perspectiveJoohee Sul, Paul G Kluetz, Elektra J Papadopoulos, et al.
Neuro-Oncology Practice|October 25, 2021
Emergency department visits and inpatient hospitalizations among older patients with brain metastases: a dual population- and institution-level analysisNayan Lamba, Paul J Catalano, Colleen Whitehouse, et al.
Neuro-Oncology Practice|October 1, 2021
Redo craniotomy or bevacizumab for symptomatic steroid-refractory true or pseudoprogression following IMRT for glioblastomaTheresa A Cook, Dasantha T Jayamanne, Helen R Wheeler, et al.
Neuro-Oncology Practice|October 1, 2021
Long-term neuropsychological outcomes of survivors of young childhood brain tumors treated on the Head Start II protocolCara F Levitch, Benjamin Malkin, Lauren Latella, et al.
Neuro-Oncology Practice|April 4, 2022
Understanding the effect of categorization of a continuous predictor with application to neuro-oncologyRuchi Gupta, Courtney N Day, Wlliam O Tobin, et al.
Pageof 73